Uncategorized - December 18, 2014
Xellia Forms Advisory Board
Xellia Pharmaceuticals, which focuses on providing important anti-infective treatments against serious and often life-threatening infections, announced the formation of a new Scientific Advisory Board (SAB). The SAB brings together leading international scientific and clinical advisors with expertise in infectious diseases, clinical microbiology, respiratory medicines and drug research and development. The SAB Chairman will be Professor […]